STOCK TITAN

Stryker (NYSE: SYK) group president awarded 9,320 performance-based shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

STRYKER CORP Group President Viju Menon reported a compensation-related stock award, not an open-market purchase. He acquired 9,320 shares of common stock at no cost as a grant tied to pre-established three-year adjusted diluted net earnings per share and sales performance goals.

The earned shares are scheduled to vest on March 21, 2026. Following this grant, Menon holds 21,831 shares directly and 198 shares indirectly through a 401(k) plan, giving a clearer picture of his overall equity stake in the company.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Menon Viju

(Last) (First) (Middle)
1941 STRYKER WAY

(Street)
PORTAGE MI 49002

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STRYKER CORP [ SYK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Group President
3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/09/2026 A(1) 9,320 A $0 21,831 D
Common Stock 198 I By 401K
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2026.
Remarks:
/s/ Austin Y. Ke, attorney-in-fact for Viju Menon 03/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Stryker (SYK) executive Viju Menon report?

Viju Menon reported receiving a grant of 9,320 Stryker common shares as compensation. The award was earned based on three-year earnings-per-share and sales goals, and represents a stock-based incentive rather than an open-market purchase or sale.

Are Viju Menon’s new Stryker (SYK) shares immediately vested?

No, the earned 9,320 Stryker shares vest on March 21, 2026. They were awarded after meeting pre-set three-year adjusted diluted net earnings per share and sales performance goals, so they function as long-term incentive compensation tied to company performance.

How many Stryker (SYK) shares does Viju Menon hold after this Form 4?

After the reported grant, Viju Menon directly holds 21,831 Stryker common shares. He also has an additional 198 shares held indirectly through a 401(k) plan, giving investors a view of his combined direct and retirement-plan equity exposure.

Was Viju Menon’s Stryker (SYK) Form 4 a market buy or sell?

The filing reflects a grant of 9,320 shares as compensation, not a market trade. The shares were acquired at no cost under a performance-based award structure and therefore do not represent an open-market purchase or sale decision.

What performance conditions were tied to Viju Menon’s Stryker (SYK) stock award?

The 9,320-share award was earned upon achieving pre-established three-year adjusted diluted net earnings per share and sales performance goals. This links Menon’s compensation directly to Stryker’s longer-term financial and revenue performance rather than short-term stock price movements.
Stryker Corp

NYSE:SYK

View SYK Stock Overview

SYK Rankings

SYK Latest News

SYK Latest SEC Filings

SYK Stock Data

128.88B
361.71M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
PORTAGE